KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 77 filers reported holding KYMERA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $67,044,274 | -39.5% | 4,823,329 | +0.0% | 0.01% | -38.1% |
| Q2 2023 | $110,873,482 | -12.8% | 4,822,683 | +12.4% | 0.02% | -16.0% |
| Q1 2023 | $127,142,862 | +11.0% | 4,291,018 | -6.5% | 0.02% | +8.7% |
| Q4 2022 | $114,593,583 | +54.3% | 4,591,089 | +34.6% | 0.02% | +43.8% |
| Q3 2022 | $74,245,000 | -25.1% | 3,410,386 | -32.3% | 0.02% | -20.0% |
| Q2 2022 | $99,137,000 | -27.4% | 5,034,940 | +56.1% | 0.02% | -13.0% |
| Q1 2022 | $136,514,000 | -20.2% | 3,225,749 | +19.7% | 0.02% | -14.8% |
| Q4 2021 | $171,093,000 | +18.0% | 2,694,814 | +9.2% | 0.03% | +8.0% |
| Q3 2021 | $144,966,000 | +261.0% | 2,467,935 | +198.1% | 0.02% | +257.1% |
| Q2 2021 | $40,155,000 | +54.4% | 827,941 | +23.7% | 0.01% | +40.0% |
| Q1 2021 | $26,009,000 | -75.0% | 669,293 | -60.4% | 0.01% | -73.7% |
| Q4 2020 | $104,050,000 | +86.4% | 1,690,579 | -4.2% | 0.02% | +58.3% |
| Q3 2020 | $55,821,000 | – | 1,764,184 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer IX & Co. Ltd. | 1,755,356 | $97,949,000 | 48.97% |
| Trustees of Columbia University in the City of New York | 463,298 | $28,724,000 | 38.38% |
| AJU IB Investment Co., Ltd. | 704,059 | $43,652,000 | 16.52% |
| BVF INC/IL | 2,630,658 | $163,101,000 | 6.42% |
| Redmile Group, LLC | 2,720,489 | $168,670,000 | 2.04% |
| Bain Capital Life Sciences Investors, LLC | 479,605 | $29,735,000 | 1.87% |
| Rock Springs Capital Management LP | 713,865 | $44,260,000 | 0.94% |
| SPHERA FUNDS MANAGEMENT LTD. | 147,700 | $9,157,000 | 0.81% |
| HighVista Strategies LLC | 17,117 | $1,061,000 | 0.68% |
| Logos Global Management LP | 110,920 | $6,877,000 | 0.59% |